Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 1,362 | 2,378 | 1,519 | 2,091 | 2,266 |
| Cost of Goods | 842 | 1,175 | 920 | 883 | 930 |
| Gross Profit | 520 | 1,203 | 599 | 1,208 | 1,336 |
| Operating Expenses | 12,605 | 9,985 | 11,110 | 7,140 | 4,342 |
| Operating Income | -11,243 | -8,607 | -9,591 | -5,049 | -2,076 |
| Interest Expense | 738 | 763 | 759 | 254 | 276 |
| Other Income | -91 | 124 | -67 | -81 | -95 |
| Pre-tax Income | -12,072 | -9,246 | -10,417 | -5,384 | -2,447 |
| Net Income Continuous | -12,072 | -9,246 | -10,417 | -5,384 | -2,447 |
| Net Income | $-12,072 | $-9,246 | $-10,417 | $-5,384 | $-2,447 |
| EPS Basic Total Ops | -0.23 | -0.19 | -0.23 | -0.12 | -0.06 |
| EPS Basic Continuous Ops | -0.23 | -0.19 | -0.23 | -0.12 | -0.06 |
| EPS Diluted Total Ops | -0.23 | -0.19 | -0.23 | -0.12 | -0.06 |
| EPS Diluted Continuous Ops | -0.23 | -0.19 | -0.23 | -0.12 | -0.06 |
| EBITDA(a) | $-10,809 | $-8,194 | $-9,122 | $-4,708 | $-1,665 |